Dare Bioscience, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2013 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Dare Bioscience, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2013 to Q3 2024.
  • Dare Bioscience, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$4.7M, a 43.3% increase year-over-year.
  • Dare Bioscience, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$3.6M, a 91.2% increase year-over-year.
  • Dare Bioscience, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$30.2M, a 2.54% increase from 2022.
  • Dare Bioscience, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$30.9M, a 20% increase from 2021.
  • Dare Bioscience, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$38.7M, a 41.2% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$3.6M -$4.7M +$3.6M +43.3% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 -$7.2M $12.9M +$21.7M Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-14
Q1 2024 -$28.9M -$6.76M +$1.29M +16% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-14
Q4 2023 -$30.2M -$5.06M +$10.9M +68.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 -$41M -$8.3M -$1.28M -18.2% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 -$39.8M -$8.76M -$9.18M -2216% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-14
Q1 2023 -$30.6M -$8.04M +$356K +4.24% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-14
Q4 2022 -$30.9M -$15.9M -$6.4M -67.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 -$24.5M -$7.02M +$5.65M +44.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$30.2M $414K +$9.58M Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-09
Q1 2022 -$39.8M -$8.4M -$1.08M -14.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-09
Q4 2021 -$38.7M -$9.54M -$1.1M -13% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 -$37.6M -$12.7M -$5.08M -67.1% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$32.5M -$9.16M -$2.04M -28.6% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-10
Q1 2021 -$30.5M -$7.32M -$3.07M -72.2% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-10
Q4 2020 -$27.4M -$8.44M -$4.58M -118% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 -$22.8M -$7.58M -$4.19M -123% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$18.6M -$7.12M -$3.17M -80.2% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-10
Q1 2020 -$15.5M -$4.25M -$1.2M -39.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-10
Q4 2019 -$14.3M -$3.87M -$950K -32.6% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-30
Q3 2019 -$13.3M -$3.39M -$819K -31.8% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 -$12.5M -$3.95M -$370K -10.3% Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-12
Q1 2019 -$12.1M -$3.05M +$4.61M +60.2% Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-12
Q4 2018 -$16.7M -$2.92M +$6.21M +68.1% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-27
Q3 2018 -$23M -$2.57M -$945K -58% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$22M -$3.58M -$3.08M -619% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 -$18.9M -$7.67M -$7.42M -3043% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
Q4 2017 -$11.5M -$9.13M -$4.19M -84.7% Oct 1, 2017 Dec 31, 2017 10-K 2019-04-01
Q3 2017 -$7.32M -$1.63M -$1.61M -10019% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 -$5.7M -$498K +$10.4M +95.4% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-13
Q1 2017 -$16.1M -$244K +$13.3M +98.2% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-14
Q4 2016 -$29.4M -$4.95M +$5.77M +53.9% Oct 1, 2016 Dec 31, 2016 10-K/A 2017-06-13
Q3 2016 -$35.1M -$16.1K +$10.5M +99.8% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-13
Q2 2016 -$45.7M -$10.9M -$952K -9.61% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 -$44.7M -$13.5M -$5.12M -60.8% Jan 1, 2016 Mar 31, 2016 10-K/A 2017-06-13
Q4 2015 -$39.6M -$10.7M -$3.25M -43.5% Oct 1, 2015 Dec 31, 2015 10-K/A 2017-06-13
Q3 2015 -$36.3M -$10.6M -$4.99M -89.8% Jul 1, 2015 Sep 30, 2015 10-K/A 2017-06-13
Q2 2015 -$31.4M -$9.91M -$2.5M -33.8% Apr 1, 2015 Jun 30, 2015 10-K/A 2017-06-13
Q1 2015 -$28.8M -$8.42M -$5.51M -189% Jan 1, 2015 Mar 31, 2015 10-K/A 2017-06-13
Q4 2014 -$23.3M -$7.47M -$3.99M -115% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-10
Q3 2014 -$19.4M -$5.56M -$2.36M -73.8% Jul 1, 2014 Sep 30, 2014 10-K 2016-03-10
Q2 2014 -$17M -$7.4M -$2.51M -51.3% Apr 1, 2014 Jun 30, 2014 10-K 2016-03-10
Q1 2014 -$14.5M -$2.91M +$2.66M +47.7% Jan 1, 2014 Mar 31, 2014 10-K 2016-03-10
Q4 2013 -$17.1M -$3.48M Oct 1, 2013 Dec 31, 2013 10-K 2016-03-10
Q3 2013 -$3.2M Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-13
Q2 2013 -$4.89M Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-12
Q1 2013 -$5.57M Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.